Tandem Diabetes Care的自动胰岛素输送系统已获得CE认证，适用范围扩展至2型糖尿病以及妊娠期1型糖尿病患者。这一认证标志着该公司产品在欧洲市场取得了重要进展，为更广泛的糖尿病患者群体提供了创新的治疗选择。自动胰岛素输送系统能够根据实时血糖监测数据自动调节胰岛素输注，有助于改善血糖控制并提升患者生活质量。此次认证的获得，预计将增强Tandem Diabetes Care在欧洲市场的竞争力，并为其未来的业务增长提供新的动力。
Tandem Diabetes Care的自动胰岛素输送系统已获得CE认证，适用范围扩展至2型糖尿病以及妊娠期1型糖尿病患者。这一认证标志着该公司产品在欧洲市场取得了重要进展，为更广泛的糖尿病患者群体提供了创新的治疗选择。自动胰岛素输送系统能够根据实时血糖监测数据自动调节胰岛素输注，有助于改善血糖控制并提升患者生活质量。此次认证的获得，预计将增强Tandem Diabetes Care在欧洲市场的竞争力，并为其未来的业务增长提供新的动力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.